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Complementary and alternative medicine (CAM) is commonly used by children with juvenile
idiopathic arthritis (JIA), yet no validated questionnaires assess that use. The objective of
this study was to develop child self- and parent proxy-report questionnaires assessing CAM
use and to determine the face and content validity of the “Which Health Approaches and
Treatments are you using?” (WHAT) questionnaires in pediatric rheumatology.
Methods
A sequential phased mixed methods approach was used to develop the questionnaires. A
Delphi Survey of 126 experts followed by an interdisciplinary consensus conference of 14
stakeholders in CAM, general pediatrics and pediatric rheumatology was held to develop
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consensus on the content of the questionnaires using a nominal group technique. To deter-
mine face and content validity of the questionnaires, two groups, including (a) a purposive
sample of 22 children with JIA 8 to 18 years and their parents from the Children’s Hospital of
Eastern Ontario and the Hospital for Sick Children, and (b) 21 Canadian pediatric rheuma-
tology experts, participated in interviews. Participants were independently asked about the
goal, understandability and comprehensiveness of the WHAT questionnaires, as well as
the relevance of items.
Results
Consensus was reached on 17 items of theWHAT questionnaires. The domains found to be
relevant were child’s CAM use, factors associated with CAM use, perceived impact of CAM
use, and communication about CAM. A total of 15 items in the parent proxy-report question-
naire and 13 items in the child report questionnaire showed adequate content validity.
Conclusions
Consensus was reached by experts on the content of a pediatric CAM questionnaire. Face
and content validity testing and modifications made to the WHAT questionnaires have
helped ensure adequate preliminary validity for use in pediatric rheumatology. This consti-
tutes the basis for further testing of these questionnaires in pediatric rheumatology and for
adaptation to other chronic diseases.
Background
Studies have shown that complementary and alternative medicine (CAM), also called comple-
mentary health approaches [1], is very common among children with chronic illnesses, such as
juvenile idiopathic arthritis (JIA) [2–7]. These treatments have been described as “health care
approaches developed outside of mainstream medicine” by the National Center for Comple-
mentary and Integrative Health (NCCIH) (formerly the National Center for Complementary
and Alternative Medicine). According to NCCIH, these treatments are usually used together
with conventional medicine, and include natural products (e.g., herbs, vitamins and minerals),
mind and body practices (e.g., acupuncture, massage, relaxation), and other complementary
health approaches (e.g., homeopathy and traditional healers) [1]. However, the lack of consen-
sus on a definition [8;9], as well as lack of standardized instruments to assess its use in clinical
practice and research [10], have led to significant variations in its reported use among pediatric
populations. In JIA for example, CAM use has been reported to range from 34% to 92% [2–7].
Using CAM in combination with conventional care may be beneficial, but may also be asso-
ciated with a higher burden of care, possibly explained by the additional time and energy
involved in using these treatments [11–13], and more difficulty in adhering to conventional
treatment [12]. One study conducted in Quebec, Canada showed that patients often pay for
CAM from their own pocket [7], since CAM is not always covered by public or private health
insurance. Drug interactions between conventional medications and CAMmay also compro-
mise potential benefits of conventional care [14]. This may be problematic since families are
often reluctant to discuss CAM with their health providers for fear of being judged [5], while
health providers do not always document its use in routine clinical care [15]. Therefore it is
essential that clinicians and researchers evaluate families’ perceptions of CAM in order to
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understand its use and its impact on health outcomes, and improve communication about
these treatments [7; 16–17].
To address this gap in clinical care and research, our research group has developed ques-
tionnaires aimed at assessing the multidimensional use of CAM in pediatric rheumatology by
families using a sequential phased approach. The current article will present results from
Phases 1 and 2. In Phase 1, we conducted a Delphi Survey and a conference of experts to gain
consensus on the content of the questionnaires, and we developed the child self- and parent
proxy-report CAM questionnaires (“Which Health Approaches and Treatments are you
using?” or WHAT) for use in pediatrics. In Phase 2, we determined the face and content valid-
ity of the questionnaires among patients with JIA, their families and experts.
Materials and Methods
Phase 1: Developing consensus on the WHAT questionnaires
We sought to develop a questionnaire that would distinguish CAM users from non-users (dis-
criminative purpose), and to document and understand their use. The questionnaire had to be
comprehensive, but also easy to use by children and parents in clinical practice, and in research
settings in a short time (i.e., under 10 minutes) [18].
This research received ethics approval from the Ottawa Hospital Research Institute, the
Children's Hospital of Eastern Ontario and the Hospital for Sick Children. An ethics consent
form was included in the Delphi Survey and in the e-mail sent to selected experts to ask them
to participate in the consensus meeting. Experts were considered to have provided their
informed content if they answered the Delphi survey and/or accepted the invitation to partici-
pate in the consensus meeting. This procedure was followed to ensure timely response to the
survey and organization of the consensus meeting. Children with JIA who took part in the face
and content validity phase provided written informed assent and one of their parents/caregiv-
ers provided written informed consent. All consent and assent material was kept and consent
was recorded in an Excel sheet. All consent procedures were approved by the aforementioned
research ethics boards.
Participant selection. We conducted a two-stage Delphi survey of Canadian and interna-
tional experts in clinical care (CAM, integrative medicine, general pediatrics, pediatric rheuma-
tology) and research (CAM, pediatric rheumatology and measurement) from the following key
stakeholder groups: (a) Pediatric Complementary and Alternative Medicine Research and Edu-
cation Network (PedCAMmembership registry; 385 members); (b) Canadian pediatric inte-
grative medicine clinic (CARE Program, Stollery Children’s Hospital, Edmonton; 11
members); (c) the Consortium of Academic Health Centers for Integrative Medicine working
group on Pediatrics (23 medical schools with a program in pediatric integrative medicine); and
(d) pediatric rheumatology organizations (e.g., Childhood Arthritis Rheumatology Research
Alliance [CARRA] and Canadian Arthritis Pediatric Rheumatology Investigators [CAPRI]; a
total of 325 members in both groups). The Delphi consisted of two iterative rounds using Sur-
vey Monkey, followed by a two-day conference of selected experts, with the goal of reaching
consensus on the domains and items that should be included in a pediatric CAM question-
naire. Selected key stakeholders included clinical experts and researchers in the field of CAM,
integrative medicine, general pediatrics and pediatric rheumatology recruited from the same
associations participating in the consensus conference. Methodologists with expertise in the
development of questionnaires, as well as consumers (i.e., young adult living with JIA and par-
ent of a child with JIA) participated. The Delphi and consensus methods are used to obtain reli-
able consensus of experts’ opinions [19–20] and have been used successfully in pediatric
rheumatology [21–23].
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Delphi procedures. Following approval from the various groups and the research ethics
boards of the Ottawa Hospital Research Institute, an e-mail (followed by two reminders over
the next six weeks) was sent to members of key stakeholder groups by the head of their organi-
zations or their delegate to ask them to participate in the Delphi process consisting of two
rounds. The e-mail described the study purpose and procedures, and directed participants to a
Survey Monkey link. Experts were asked about the importance of developing a CAM question-
naire for use in clinical practice and research, and to provide opinions on the appropriateness
of domains that should be included in a pediatric CAMmeasure based on key domains identi-
fied in a systematic review of pediatric CAM questionnaires [10]. Experts were asked to rate
domains using a scale from 1 to 5 where 1 = “not at all important” and 5 = “very important”.
Each domain and item with at least 75% of participants rating it as important or very important
was deemed to have achieved consensus and was retained for the second round. In the second
round, experts were presented with ratings on domains from Round 1 that did not achieve con-
sensus, and asked to reconsider their answers. They were also asked to rate the relevance and
ways of assessing items for each domain on which consensus was achieved in Round 1, and on
new domains that were suggested. A brief demographic form gathered information concerning
the Delphi participants (i.e., geographic location, affiliation with a key stakeholder group, pro-
fession and expertise in CAM research and clinical practice). Both rounds were pilot tested
with six experts in the field of CAM to ensure the clarity and acceptability of the questions.
Consensus conference procedures. A two-day consensus conference with selected key
stakeholders was conducted to reach consensus on the final questionnaire. A study information
letter was sent to targeted experts in an introductory e-mail from the research team to ask them
to participate in a consensus conference. The interdisciplinary consensus conference was con-
ducted using nominal group technique with 14 stakeholders, and was facilitated by Dr. Adam
Huber, who has chaired similar meetings (i.e., consensus meetings on juvenile dermatomyositis
treatments)[24], and co-chaired by Drs. Stinson and Toupin April. The consensus conference
was audio recorded and results of the votes were recorded in an Excel sheet. Panel members were
presented with information on the content of existing pediatric CAM questionnaires gathered
from the systematic review, as well as domains and items found to be relevant according to the
Delphi survey. Experts were asked to determine the domains and items that were essential to the
questionnaires, and which scales should be used. Domains and items were presented, and experts
were given five minutes for silent reflection. Each could then present their position for up to two
minutes without being interrupted. Experts had another chance to present their position and
then a hand, ballot or sticker vote was taken, depending on the type of question at hand. Domains
and items were included in the questionnaire if they were found essential by at least 75% of
experts agreed [20]. If this consensus threshold was not reached, experts had a last opportunity
to present their position, and discussions resolved disagreements. If consensus was not reached,
the item was not included and the group moved on to another question.
Development of the questionnaires. The research team agreed upon additional items
suggested by conference attendees, and developed the WHAT child and parent self-report
questionnaires. A conceptual framework has been developed to represent the domains and
items assessed by the new questionnaires (see S1 Fig).
Phase 2: Assessing the face and content validity of the WHAT
questionnaires
The criteria of the COSMIN checklist were used to assess the face and content validity of the
questionnaires among patients with JIA, their parents and Canadian pediatric rheumatology
experts. The COSMIN checklist is an instrument that proposes criteria to judge the
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methodological quality of studies of measurement properties for health status measurement
instruments [25–28]. The Terwee quality criteria [29] were used for rating measurement prop-
erties. While the COSMIN checklist helps to judge the methods of the studies that validate an
instrument, the Terwee criteria evaluate the results of these studies.
Participant selection. A total of 21 health care providers and researchers in the field of
pediatric rheumatology were recruited from the Children’s Hospital of Eastern Ontario, the
Hospital for Sick Children and among members of the Canadian Arthritis Network to test the
content validity of the measures.
A purposive sample of 22 children and youth aged 8 to 18 years, and one of their parents/
primary caregivers, were recruited from the Children’s Hospital of Eastern Ontario and the
Hospital for Sick Children rheumatology clinics. Children and their parents were approached
if they could understand and speak English, and if children were undergoing treatment for JIA
at one of the two rheumatology clinics. Family members were included in the study only if they
were living with the child. Children were excluded if they had (a) cognitive impairments, or (b)
major co-morbid illnesses, which could impact their ability to understand and participate fully
in the study. The sample was heterogeneous at each site in terms of age (8–12 and 13–18 year
old), disease severity and CAM use.
Procedures. Children/youth and parents/caregivers, as well as health care professionals
were asked to complete a socio-demographic form, read theWHAT questionnaires and partici-
pate in an interview. During the interview, they were asked to look at each item and consider
whether or not all items referred to relevant aspects of the constructs to be measured for the
purpose of the instrument (i.e., to distinguish CAM users from non-users, and to document
and understand their use) and the population of interest (i.e., children with JIA and their
parents). They were also asked whether there were items missing from the CAM question-
naires. The importance of each domain and item was also rated on a three-point scale (“essen-
tial”, “useful but not essential” or “not necessary”) by respondents using the content validity
rating form. The percentage of agreement among parents, children and health professionals
who rated an item to be essential or useful (good agreement being defined by at least 75% of
parents/children) was then calculated. Clinical data (e.g., age, JIA subtype, disease severity, dis-
ease duration) was also collected from the children’s medical charts.
Measures. A brief socio-demographic form gathered information concerning the health
care professionals’ profession and years of experience. A more thorough questionnaire was
used for children and parents/caregivers in order to inquire about the children’s age and sex,
family income, parents’/caregivers’ level of education, and cultural background. The forms
were pilot tested before use.
The content validity rating form served as a guide for the interview and enabled health care
professionals, as well as parents and children, to determine their understanding, as well as the
relevance and the comprehensiveness of the items of the CAM questionnaires.
Clinical data were also collected from the participants’medical charts (type of arthritis, pre-
scribed treatment, disease duration, disease severity [active joint count, representing the num-
ber of joints with active inflammation as evaluated by the rheumatologist).
Data analysis. The quantitative data from the questionnaires was coded and entered into
the Statistical Package for the Social Sciences database. Descriptive statistics were used to
describe the participant characteristics and the agreement between participants concerning the
relevance of items in the questionnaires.
Items were included in the questionnaires based on participants’ relevance ratings and the
rationale they provided, as well as discussions among team members.
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Results
Phase 1 Developing consensus on the WHAT questionnaires
Participants. The first round of the Delphi was completed by 126 experts, coming from
Canada (n = 44), the United States (n = 64) and Europe (n = 5). Respondents were members of
CARRA (n = 69), CAPRI (n = 26), PedCAM (n = 24), CAHCIM (n = 13) and the CARE pro-
gram for integrative health and healing (n = 4). Out of a total of 72 experts who provided their
e-mail address to participate in the second round, 76.4% (n = 55) completed the second survey.
The second round participants came from Canada (n = 26), the United States (n = 25) and
Europe (n = 4). Respondents were members of CARRA (n = 27), CAPRI (n = 13), PedCAM
(n = 16), CAHCIM (n = 7) and the CARE program (n = 4). The consensus conference included
14 stakeholders who attended the face-to-face meeting. A summary of the characteristics of
experts is shown in Table 1.
Delphi: First round results. A total of 88.1% (n = 111) of experts felt that it was important
to assess the use of CAM by children in a pediatric clinical setting using a questionnaire, 9.5%
(n = 12) were unsure, and 2.4% (n = 3) felt that it was not important. Some participants raised
the issue that it may be difficult to assess CAM use at every visit as their health care providers
often have limited knowledge in CAM and do not necessarily find the time to thoroughly assess
and discuss CAM in a consultation.
Domains that were presented to experts included items describing a child’s CAM use, fac-
tors associated with CAM use, perceived impact of CAM use and communication about CAM.
Each of these domains included items that were agreed upon by experts. Percentages of agree-
ment concerning the relevance of each item are found in Table 2. 16 items were agreed upon
by 75% or more experts, and seven items showed a lower agreement. The items which showed
the strongest endorsement by experts focused on characteristics of CAM use and associated
factors (e.g., types, frequency, health condition treated), perceived effectiveness and safety of
CAM, communication with conventional providers about CAM, and use of conventional treat-
ments while using CAM. Although frequency, duration and dosage of CAM were thought to
be important, some participants mentioned that these items would depend on the modality
used, and may be too precise for monitoring CAM use in routine clinical rheumatology prac-
tice. Participants also reported that CAMmay be used for wellness and not just for a chronic
health condition, which should be acknowledged by a CAM questionnaire.
Table 1. Characteristics of the experts involved in the development of theWHAT questionnaire.
Round 1 Round 2 Consensus conference
n = 126 n = 55 n = 14
n (%) n (%) n (%)
Profession
Medical doctor 86 (76.8) 35 (63.6) 5 (35.7)
CAM provider 19 (17) 13 (23.6) 5 (35.7)
Other conventional provider 5 (4.5) 3 (5.5) 2 (14.3)
Researcher 26 (23.2) 9 (16.4) 12 (85.7)
Patient/parent ____ ____ 2 (14.3)
Expertise
CAM practice 49 (46.2) 29 (58.0) 5 (35.7)
CAM research 41 (37.6) 21 (41.2) 7 (50)
Pediatric rheumatology care ____ ____ 8 (57.1)
Pediatric rheumatology research ____ ____ 6 (42.9)
doi:10.1371/journal.pone.0149809.t001
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The types of CAM that were felt to be the most important to list in the questionnaire were
acupuncture (n = 87, 77.7%), herbal medicine (n = 83, 74.1%), dietary supplements (n = 82,
73.2%), chiropractic (n = 81, 72.3%) and dietary changes (n = 77, 68.8%), but a few participants
mentioned the importance of regrouping types of CAM within broader categories of CAM, as
many felt a questionnaire could not list all the possible CAM types. 85.8% (n = 103) felt that
examples of CAM should be provided for each category. 75.8% (n = 91) of experts thought that
CAM should be defined in the questionnaire, and 87.5% (n = 105) thought that the various
types or categories of CAM should be defined as well. Some participants also suggested that the
following items be added: nature of the information provided about CAM (n = 3); positive con-
sequences/benefits of CAM use (n = 3); source and brand of CAM products (n = 2); person
who provided CAM service (n = 2); and qualifications of CAM providers (n = 1).
Delphi: Second round results. It was not possible to achieve consensus on a definition of
CAM. The definition of CAM that was felt to be the most appropriate by participants (n = 26,
48.1%) for inclusion in the questionnaire was the one previously proposed by the NCCIH. This
definition states that “CAM is a group of diverse medical and health care systems, practices
Table 2. Agreement by experts on the domains of a CAM questionnaire.
Item Round 1 Round 2 Consensus conference
N (%) N (%) N (%)
Use of conventional treatments while using CAM 107 (95.5) 48 (87.3) 14 (100)
Types of CAM used by the child 106 (94.6) 52 (94.5) 14 (100)
Health condition treated by CAM 106 (94.6) 52 (94.5) 13 (100)
Positive consequences/beneﬁts of CAM ————- 51 (92.7) 13 (92.9)
Perceived safety of CAM 105 (93.8) 48 (87.3) 11 (84.6)
Negative consequences of CAM 105 (93.8) 46 (83.6) 11 (78.6)
Frequency of CAM use 103 (92.8) 49 (89.1) 13 (92.9)
Communication with heath care providers about CAM 104 (92.9) 48 (87.3) 14 (100)
Reasons for CAM use/non-use 99 (88.4) 46 (83.6) 13 (100)
Perceived effectiveness of CAM 99 (88.4) 48 (87.3) 10 (76.9)
Duration of CAM use 97 (87.4) 46 (83.6) 12 (85.7)
Timing of CAM use compared to use of conventional care 92 (82.9) 39 (70.9) 5 (35.7)
Dosage of CAM 90 (81.8) 40 (72.7) 1 (7.1)
Expectations about CAM use 88 (80.7) 47 (85.5) —————-
Source of information about CAM 90 (78.9) 42 (79.2) 9 (69.2)
Person who decided to use CAM 86 (76.8) 36 (67.9) 11 (78.6)
Timing of CAM use compared to diagnosis 82 (75.2) 36 (65.5) 3 (21.4)
Parent/family use of CAM 85 (73.9) 43 (81.1) 12 (85.7)
Interest in using CAM in the future 82 (73.9) 26 (47.3) 0 (0)
Costs of CAM use 78 (70.3) 32 (58.2) 14 (100)
Financial burden of CAM ————— ————— 11 (84.6)
Person who recommended CAM use 75 (66.4) 33 (62.3) 0 (0)
Interest in learning about CAM 66 (59.5) 15 (27.3) 0 (0)
Interest in recommending CAM to other parents 64 (57.7) 13 (23.6) 0 (0)
Difﬁculty in accessing CAM 56 (49.6) 15 (28.3) 14 (100)
Nature of the information provided about CAM ————- 32 (60.4)
By conventional providers: 2 (14.3)
By CAM providers: 0 (0)
Brand of CAM product ————- 18 (32.7) 0 (0)
Qualiﬁcations of CAM providers ————- 31 (58.5) 0 (0)
doi:10.1371/journal.pone.0149809.t002
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and products that are not presently considered to be part of conventional Western medicine”.
The definition proposed by the Cochrane Collaboration was also preferred by some partici-
pants (n = 9, 16.7%)
A high proportion of participants (n = 36, 66.7%) also felt that types of CAM should be
regrouped within broader categories of CAM, as many felt a questionnaire could not list all the
possible CAM types. 10 participants (18.5%) were unsure about the need for categories. Some
participants mentioned that categories may overlap, and that this may be confusing for
patients, especially if the names of the categories are created by experts and not clear to patients
(e.g., biological based therapies). The 2010 NCCAM classification (which includes (1) Alterna-
tive medical systems (e.g., acupuncture, homeopathic, naturopathic), (2) Biological based ther-
apies (e.g., diets, herbals, supplements), (3) Manipulative and body-based therapies (e.g.,
sensory integration, chiropractic, massage), and (4) Mind-body and psychological therapies (e.
g., music therapy, spiritual healing)) was the one preferred by participants (n = 16, 44.4%).
Then followed the 2011 NCCIH classification, which replaced the “alternative medical sys-
tems” category and “biological based therapies” in the 2010 classification by “natural products”
and “other CAM practices”. Finally, Martel’s classification followed (n = 10, 27.8% each) [30].
This classification includes five domains: (1) natural products (e.g., herbal remedies/homeopa-
thy/vitamins); (2) nutritional approach (e.g., diets or special food); (3) spiritual/mental strate-
gies (e.g., hypnosis, imagery, prayer, relaxation, meditation; (4) physical strategies (e.g.,
acupuncture, massage, chiropractic, yoga); and (5) other (e.g., aromatherapy) [30]. A few par-
ticipants also proposed merging the various classifications (i.e., 2010 and 2011 NCCIH and
Martel, 2005) in order to create clearer and more representative categories. 59.3% (n = 32) felt
that the various categories of the classification and the types of CAM listed should be defined,
and 29.6% (n = 16) felt that only the categories of CAM should be defined. Some participants
mentioned that definitions may be restrictive and may preclude patients from disclosing all of
the CAM types they have used.
14 items were agreed upon by 75% or more experts, and 13 showed a lower agreement (see
Table 2). Overall, results were consistent with the first round of the Delphi. Of the items that
showed the strongest endorsement by experts, most were similar to those from Round 1, and
represented all four domains. However, a few items describing CAM use that were felt relevant
in Round 1 fell below the 75% threshold (e.g., timing of CAM use compared to diagnosis and
use of conventional care, and dosage of CAM products), and one item gained a few percentage
points to become relevant (i.e., parent and family use of CAM). Most items that were felt not to
be relevant in Round 1 remained so, and focused on the difficulty of accessing CAM, the inter-
est in learning about CAM, using it in the future, and recommending it to other parents. The
other items suggested in Round 1 (i.e., brand of CAM, qualifications of the CAM providers,
nature of the information provided about CAM) were not felt to be relevant in Round 2.
When asked to determine a timeframe of CAM use that should be assessed, participants felt
that child’s current use was the most important to assess (65.4%), followed by use since the
clinical diagnosis (50%), use in the last month and last year (36.5% each) and lifetime use
(32.7%). Two participants also suggested assessing CAM use since the last visit in the case of
consultation in a rheumatology clinic. With respect to parent and family use of CAM, current
and lifetime use were the most important (49.1% and 43.6% respectively). When asked which
negative consequences should be assessed, major and minor side effects (92.7% and 70.9%
respectively), as well as interactions with conventional care (85.5%) and financial costs (56.4%)
were the most common. With respect to costs, out of pocket costs (58.5%) and overall costs of
CAM (54.7%) were the most common. Aspects of communications which were felt to be most
important asked whether patients felt comfortable discussing CAM with their health providers
(79.6%), and whether they felt their health providers were open to the discussion (77.8%).
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Finally, other elements that were found to be important were whether patients had modified
(96.3%), stopped (85.2%) or delayed (79.6%) their conventional care because they were using
CAM.
As we aimed to have a questionnaire that would be comprehensive, but also easy to use, and
the fact that various comments by respondents needed to be addressed further, a consensus
conference of selected stakeholders was undertaken to discuss the content of the questionnaire
in more depth.
Results from the consensus conference. Consensus meeting stakeholders felt that existing
CAM definitions may be too difficult to understand for families. Thus, they suggested a short
preamble asking respondents to list all treatments that were not necessarily prescribed by their
conventional care providers. They also felt that types of CAM should be regrouped within
broader categories of CAM along with examples, and votes were divided between the classifica-
tion proposed by Martel in 2005 and the Norwegian National Research Center in Complemen-
tary and Alternative Medicine classification which includes the following domains: (1) visiting
health care providers; (2) complementary therapies received by physicians; (3) use of herbal
medicine and dietary supplements; and (4) self-help practices) [30–31]. When asked to vote
with five stickers each, stakeholders preferred the Martel classification (38 votes vs. 27 votes).
This classification was liked because it separates CAM services from products, and considers
whether individuals consulted a health care provider to use CAM.
All four CAM domains were found to be relevant according to stakeholders: child’s CAM
use, factors associated with CAM use, perceived impact of CAM use and communication about
CAM. A total of 16 out of 29 items were agreed upon at the conference.
Most items that were felt to be relevant in the consensus conference were also the core items
considered the most important in the two rounds of the Delphi. These items included charac-
teristics of CAM use and associated factors (e.g., types, frequency, treated health condition
duration, reasons), perceived effectiveness and safety of CAM, and the use of conventional
treatments while using CAM. Parent/family use of CAM showed similar results to Round 2 of
the Delphi, and was felt to be relevant by stakeholders. Communication with conventional care
providers about CAM was also perceived to be a domain that was important and required fur-
ther discussion, although there was no formal vote to determine its inclusion in the question-
naire. Contrary to the Delphi results, items related to access to CAM (i.e., difficulty of access,
cost, and financial burden) and to the person who made the decision to use CAM were found
to be relevant. Other items focusing on characteristics of CAM use (i.e., dosage and brand of
CAM products, timing of CAM use), characteristics of individuals who recommended or
offered CAM (i.e., person who recommended CAM and qualifications of CAM provider), and
CAM information (i.e., source, nature of information, interest in learning about CAM) were
not felt relevant by consensus conference participants. Other irrelevant items were linked to
the perceived impact of CAM use (e.g., interest in using CAM in the future and in recommend-
ing CAM to others). Most of the items that were felt irrelevant were difficult to assess in a valid
manner or were too specific to be used.
General attitudes and beliefs towards CAM, such as expectations about CAM, were items
that were not felt to be crucial to assess CAM use. In addition, the panel members felt that dis-
ease severity and socio-demographic information were important to assess, but should possibly
be in a separate questionnaire.
Resulting questionnaires. The research team, which included measure development
experts, developed the parent-report and child self-report questionnaires based on the results
from the Delphi and consensus conference, as well as discussions within the research team. In
order to ensure the feasibility and acceptability of the questionnaires, some items that were dif-
ficult to measure were deleted (e.g., frequency, duration and dosage of the various CAM
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modalities), and some items were merged together (e.g., health condition could be named as a
reason of use, cost could be listed as a reason for having difficulty accessing CAM and as a dis-
advantage of CAM). Three additional items were proposed by experts and agreed upon: (1)
whether individuals consulted a health care provider to use CAM; (2) the reasons for not using
CAM and; (3) the communication about CAM within the family.
The resulting versions of the WHAT self and proxy report questionnaires (see S1 and S2
Appendices) included 17 and 12 items, respectively. A preamble was included to describe CAM
modalities along with the Martel classification and examples of CAMmodalities for each CAM
category. A question was also added to inquire about the use of conventional care, since team
members felt that it would help to make a distinction between CAM and conventional care.
Phase 2: Assessing the face and content validity of the WHAT
questionnaires
Participants. A purposive sample of 22 children and youth aged 8 to 18 years, and one of
their parents/primary caregivers, as well as 21 health care professionals, were recruited. Socio-
demographic and disease-related characteristics of youth and parents are included in Table 3.
Health professionals belong to various professions: rheumatology (n = 7), nursing (n = 5),
physiotherapy (n = 4), occupational therapy (n = 2), research coordination (n = 1), psychiatry
(n = 1) and social work (n = 1). They had an average of 19 years of experience (standard devia-
tion = 10.3, range = 1–37) in their profession.
Face and content validity results. Concerning face validity as assessed by the COSMIN
checklist, children with JIA, parents and health care professionals were able to understand the
purpose of the questionnaires and felt that the questionnaires appeared to be an adequate
reflection of the multidimensional use of CAM. Participants found most questions easy to
understand and answer except for the table that asked them various questions on each type of
CAM children had used. The formatting of the table was found to be confusing by participants
(i.e., confusion about where to start reading the table and about the need to answer the ques-
tions in each column for the CAMmodality on each line of the table). They adequately com-
pleted all questions of the WHAT questionnaires, but sometimes forgot to provide
clarifications about their answers in the table, possibly because there were too many instruc-
tions. Participants, especially younger children and those who had not used CAM and thus
were not familiar with many of the CAM examples provided sometimes had difficulty making
the distinction between CAM and conventional care (e.g., physiotherapy vs. chiropractic).
Also, they sometimes had difficulty understanding some terms such as benefits and disadvan-
tages of CAM. Both parents and children completed questionnaires with a research assistant.
However, more explanations about the definition and examples of CAM, as well as examples of
benefits and disadvantages of CAM, were provided by the research assistant to younger chil-
dren and those who had never used CAM if they had difficulty understanding. Children took a
mean of 9.9 minutes (SD = 4.1 minutes) and parents took a mean of 8.3 minutes (SD = 3.1
minutes) to complete the WHAT questionnaires in clinic.
Concerning content validity, questionnaires were felt to comprehensively represent relevant
aspects of CAM use. However, some items were not felt to be relevant for the purpose of the
questionnaire and the population surveyed. Furthermore, children, parents and health care
professionals did not always agree on which items to include, which led to a discussion within
the research team to determine which items to include in the questionnaires. Results of the
content validity for the WHAT parent report questionnaire are shown in Table 4.
A total of 14 out of 17 items showed adequate content validity in the parent proxy-report
questionnaire, including items from each domain: past and current CAM use by the child,
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types of CAM used by the child in the past two weeks, reasons for CAM use and non-use, diffi-
culty in accessing CAM, whether a health provider was consulted to use CAM, the person who
decided to use CAM, CAM perceived helpfulness, CAM benefits and risks, modification to
conventional treatments because of CAM and communication about CAM with conventional
care providers and within the family. These items were included in the parent proxy-report
questionnaire. Some items were not included in the questionnaire because less than 75% found
them useful (i.e., modes of payment for CAM) or because they were felt to assess a different
construct (i.e., parent/family CAM use, source of information about CAM). An additional item
was also added to inquire about the intent to use CAM in the future for the child, as it was felt
to be important to assess in a clinical context after a review of the results of the content validity
testing. A discussion within the research team, in light of the Delphi survey, consensus confer-
ence and validation study, concluded that these 15 items should be kept.
Table 3. Socio-demographic and disease-related characteristics of youth and their parents.
Characteristics Ottawa Toronto Total
N = 12 N = 10 N = 22
Mean age, years (SD) 13.1 (2.7) 13.6 (2.4) 13.3 (2.5)
Mean disease duration, years (SD) 7.4 (5.4) 8.1 (4.8) 7.6 (4.8)
Active Joint Count, mean (SD) 0.7 (1.3) 0.3 (0.7) 0.5 (1.0)
Active Inﬂammation, n (%) 3 (25) 2 (20) 5 (22.7)
Exercise program, n (%) 1 (8.3) 2 (20) 3 (13.6)
Splint, n (%) 0 0 0
Income
Less than $14,999 0 0 0
$15,000-$24,999 0 1 (10) 1 (4.5)
$25,000-$34,999 0 1 (10) 1 (4.5)
$35,000-$44,999 0 0 0
$45,000-$54,999 0 0 0
$55,000-$64,999 1 (8.3) 0 1 (4.5)
$65,000-$74,999 1 (8.3) 0 1 (4.5)
$75,000-$84,999 2 (16.6) 1(10) 3 (13.6)
$85,000-$94,999 4 (33.3) 1(10) 5 (22.7)
More than $95,000 4 (33.3) 6 (60) 10 (45.4)
Culture
Canadian 10 (83.3) 5 (50) 15 (68.2)
European 2 (16.6) 3 (30) 5 (22.7)
Asian 0 1 (10) 1 (4.5)
Haitian/Caribbean 0 1 (10) 1 (4.5)
Other 0 0 0
Education of Mothers
Not high-school 0 0 0 (0)
High-school 2 (16.6) 3 (30) 5 (22.7)
College 3 (25) 4 (40) 7 (31.8)
University 7 (58.3) 3 (30) 10 (45.4)
Education of Fathers
Not high-school 0 1 (10) 1 (4.5)
High-school 0 0 0 (0)
College 6 (50) 3 (30) 9 (40.9)
University 6 (50) 6 (60) 12 (54.5)
doi:10.1371/journal.pone.0149809.t003
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In the child report questionnaire, all 12 items were agreed upon by children and health pro-
fessionals, with children’s ratings being lower than those of experts for all items, as shown in
Table 5. These were past and current CAM use by the child, types of CAM used by the child in
the past two weeks, reasons for CAM use and non-use, the person who decided to use CAM for
the child, CAM perceived helpfulness, CAM benefits and risks, modification to conventional
treatments because of CAM, and communication about CAM with conventional care providers
and within the family. Discussions among the team resolved the issues regarding one of these
Table 4. Agreement by raters concerning the content validity of the items of the parent report WHAT questionnaire.
Item Health expert Parent Total Judgment
N (%)* N (%)* N (%)*
Current use of CAM by the child 21 (100) 20 (100) 41 (100) Include item
Types of CAM used 20 (100) 20 (100) 40 (100) Include item
Modiﬁcation of conventional treatments because of CAM 21 (100) 20 (100) 41 (100) Include item
Past use of complementary medicine by the child 21 (100) 20 (95) 41 (98) Include item
Parent/family CAM use 20 (100) 18 (90) 38 (95) Exclude item
Consultation with CAM provider 20 (100) 15 (79) 35 (90) Include item
Person who decided to use CAM 21 (100) 14 (70) 35 (85) Include item
Communication about CAM with heath care providers 19 (95) 18 (95) 37 (95) Include item
Reasons for CAM use 19 (95) 18 (95) 37 (95) Include item
Reasons for non-use of CAM 19 (95) 13 (87) 32 (91) Include item
Communication about CAM within the family 20 (95) 14 (70) 34 (83) Include item
Beneﬁts of CAM 18 (90) 18 (95) 36 (92) Include item
Risks of CAM 18 (90) 18 (95) 36 (92) Include item
Source of information about CAM 18 (90) 14 (82) 32 (89) Exclude item
Modes of payment for CAM use 18 (90) 10 (53) 28 (72) Exclude item
Helpfulness of CAM types 17 (85) 17 (85) 34 (85) Include item
Difﬁculty to access CAM 17 (81) 14 (74) 31 (78) Include item
* Number and percentage of raters who found the item to be essential or useful
doi:10.1371/journal.pone.0149809.t004
Table 5. Agreement by raters concerning the content validity of the items of the child report WHAT questionnaire.
Item Health expert Child Total Judgment
N (%)* N (%)* N (%)*
Current use of CAM by child 15 (100) 20 (100) 35 (100) Include item
Types of CAM used 14 (100) 18 (100) 32 (100) Include item
Past use of complementary medicine by the child 15 (100) 21 (100) 36 (100) Include item
Modiﬁcation of conventional treatments because of CAM 15 (100) 19 (100) 34 (100) Include item
Person who decided to use CAM 15 (100) 12 (67) 27 (82) Include item
Communication about CAM with health care providers 20 (95) 12 (100) 32 (97) Include item
Reasons for CAM use 13 (93) 17 (94) 30 (94) Include item
Reasons for non-use of CAM 14 (93) 12 (80) 26 (87) Include item
Communication about CAM within the family 13 (87) 15 (79) 28 (82) Include item
Beneﬁts of CAM 12 (86) 16 (94) 28 (90) Include item
Risks of CAM 12 (80) 13 (87) 25 (86) Include item
Helpfulness of CAM types 11 (79) 17 (94) 28 (88) Include item
* Number and percentage of raters who found the item to be essential or useful
doi:10.1371/journal.pone.0149809.t005
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items, which had lower scores for children than health professionals (i.e., the person who
decided to use CAM for the child). Another item was added by the research team since it was
felt to be important by participants (i.e., intent to use CAM in the future for the child), leading
to 13 included items.
After modifying the layout of the tables in the questionnaires, simplifying the wording to
ensure an adequate reading level, and adding examples to make them easier to complete, our
research team showed the updated WHAT questionnaires to key stakeholders (i.e., 16 health
professionals and 15 patients who were part of our study) to confirm content validity and
appropriate formatting. Feedback from these experts and families confirmed the comprehen-
siveness and relevance of included items (considering the purpose of the questionnaires, the
population of interest and the construct being assessed), as well as the understandability of the
questionnaires. Content validity of the WHAT questionnaires was considered adequate
according to the COSMIN checklist and the Terwee criteria. When assessed using the Flesch-
Kincaid reading ease, the parent and child questionnaires gave scores of 75.7 and 73.7 respec-
tively. The grade levels were 4.5 and 4.8 respectively.
Discussion
This article presents results of the development and preliminary face and content validation of
the WHAT questionnaires, which assess CAM use in a multidimensional manner. A validated
phased approach consisting of an electronic two-round Delphi survey of experts and a consen-
sus conference of key stakeholders, including clinicians, researchers and patients, was used to
reach consensus on the domains and items of the questionnaire. The questionnaires were then
tested for face and content validity with patients and rheumatology professionals at two sites.
Contrary to most existing CAM questionnaires, both health care providers and patients
were involved in developing and evaluating face and content validity of the present question-
naires [10]. Using a phased approach consisting of a Delphi survey and consensus conference
with key stakeholders will ensure that our questionnaires target key aspects of CAM and are
useful to clinicians, researchers and families. Furthermore, evaluating the face and content
validity of the CAM questionnaires among children with JIA, their parents and health profes-
sionals is a crucial first step in ensuring adequate measurement properties of the WHAT ques-
tionnaires, to allow their use in pediatric rheumatology clinical practice and research.
Results from the Delphi, consensus conference and validity testing revealed that most par-
ticipants thought it was important to assess the use of CAM by children in a pediatric clinical
setting using a questionnaire. This is consistent with other studies, which have advocated that
monitoring CAM in clinical practice is important [7;16–17] not only to reduce potential side
effects and interactions with conventional medications, but also to understand CAM use and
its impact on health outcomes, which may lead to a more integrated way of treating patients
with chronic diseases.
Involving key stakeholders also provided some input on how to describe CAM in order to
assess its use, and how to select the most important items related to CAM use, which may
resolve the lack of consistency among CAM questionnaires [10] and provide a valid multidi-
mensional assessment of CAM use. Providing a short preamble explaining what CAM is, a
classification of CAM along with examples, as well as a question to inquire about the use of
conventional care to help respondents make the distinction between CAM and conventional
care seems to be a good approach, as children with JIA, parents and health care professionals
were able to understand the purpose of the questionnaires. Since the distinction between CAM
and conventional care becomes blurrier over time as CAM becomes more integrated into con-
ventional care, this approach helps to ensure that all treatments are listed, even if patients are
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unsure how to classify them. Furthermore, the core set of domains (and items) which emerged
from the Delphi, consensus conference, content validation and discussions among team mem-
bers included the child’s CAM use (e.g., types, person who was consulted), the factors associ-
ated with CAM use (e.g., reasons including treated symptoms, access), the perceived impact of
CAM use (e.g., CAM benefits and risks, modification of conventional care because of CAM
use) and the communication about CAM (e.g., with health providers, within the family). These
domains and items are consistent with the content of most existing CAM questionnaires [10],
except for a few items that are typically not assessed by CAM questionnaires (e.g., symptoms
treated by CAM, CAM benefits and risks, modification of conventional care because of CAM
use), but have been found to be relevant in various studies.
Another addition to the current literature is the use of the COSMIN checklist and the Ter-
wee criteria to guide the preliminary validation of the parent proxy-report and child report of
the WHAT questionnaires. This will ensure a rigorous validation process that no other CAM
questionnaire has followed, since the content validity of existing CAM questionnaires is inde-
terminate according to the COSMIN checklist and the Terwee criteria due to lack of clarity of
their findings (i.e., purpose of the questionnaire, concepts to measure, involvement of the target
of the population, methods of item selection and reduction), as shown by an existing systematic
review [10].
Finally, a child self-report questionnaire was developed, which is uncommon in existing
CAM questionnaires according to the results of our systematic review (i.e., 23% of CAM ques-
tionnaires). It also showed an approximate grade level of 5, which means that it could be easily
understood and completed by children 11 years old and older. Developing both parent proxy-
report and child report WHAT questionnaires may also allow for comparison of parents’ and
children’s perceptions regarding CAM use, which has not previously been investigated, and
would merit attention.
Limitations
One of the limitations of the development process of the WHAT questionnaires is the high per-
centage of participants who discontinued their participation in the Delphi after Round 1 (i.e.,
56.3%). This may have led to a selection bias since participants from Rounds 1 and 2 may have
different characteristics that may change results. However, this bias does not seem to have neg-
ative consequences as participants from Round 2 seem to have more expertise on the topic.
Possibly, participants from Round 1 who had less expertise and interest in this topic withdrew
from further participation in the Delphi.
Additionally, while the use of the percentage of agreement among participants has helped to
quantify the agreement between raters to ensure a rigorous assessment of content validity, the
cut-off for item inclusion is not definitive. To solve this issue, the research team considered the
respective scores along with the rationale provided by parents, children and health care profes-
sionals in order to decide upon inclusion of items.
Conclusion
The current work represents the first steps to developing a CAM questionnaire for use in pedi-
atrics and validating it in children with JIA and their parents. Consensus was reached by
experts on the content of a pediatric CAM questionnaire, and the parent-report and child self-
report of the WHAT questionnaire were developed. Face and content validity testing and mod-
ifications made to the WHAT questionnaires have helped ensure adequate preliminary validity
for use in pediatric rheumatology. The next steps of the validation process will be to determine
the construct validity, reliability, feasibility and acceptability of the new version of the WHAT
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questionnaires among children with JIA and their parents. Once the questionnaires are rigor-
ously validated, clinicians will be able to document CAM use more systematically, possibly
leading to better communication and knowledge exchange about benefits and risks of CAM
between families and health providers. This may also improve the quality of CAM research
and, once validated in other pediatric populations, would enable the comparison of results
from studies conducted in various other populations.
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